Samsung BioLogics has fought accusations that it inflated the value of its Biogen biosimilar joint venture Samsung Bioepis, breaking accounting rules in the process. Counter to that defense? The fact that several executives destroyed and hid evidence. And now, three of those execs could face jail time.
More: Samsung execs face jail for destroying evidence in Biogen JV fraud probe